论文部分内容阅读
在欧洲,一旦在药方中出现了假药,药厂和药品包装供应商将分别承担相应的责任和义务。患者由于服用了假药而受到损伤,那么药厂必须在法庭上出示其防伪防假证明。药厂如果在这方面的工作根本没做或做得很少,则可定为“组织机构薄弱”,必须承担应尽的义务,如果药厂在技术上已经尽
In Europe, pharmaceuticals and pharmaceutical packaging suppliers assume respective responsibilities and obligations when counterfeit drugs appear in their prescriptions. The patient is damaged as a result of taking a fake drug and the pharmaceutical company must present proof of its anti-counterfeiting and falsification in court. If pharmaceutical companies do not do very little or do very little work in this area, they may be classified as “weak organizational structures” and must assume their due obligations. If the pharmaceutical factories are technically exhausted